Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002348596 | SCV002654364 | likely benign | Cardiovascular phenotype | 2021-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003737019 | SCV004565332 | likely benign | not provided | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003769865 | SCV004574861 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-05-13 | criteria provided, single submitter | clinical testing | |
GENin |
RCV004998677 | SCV005620391 | likely benign | Familial hypercholesterolemia | 2025-01-09 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted to impact splicing and occurs at a nucleotide which is not highly conserved. This variant has been classified as Likely Benign (BP4, BP7). |